BBSRC

The DNA foundries have been funded through an £18 million ($23.5 million) investment from the BBSRC and should all be fully operational by next year.

A group of organizations in the UK say that there needs to be discussions about the use of technologies such as CRISPR/Cas-9 for human germline editing.

The partners received £30,000 (about $46,000) in funding from the BBSRC to support their metabolomics data-sharing and analyses activities.

£30M will go toward the creation of three new Synthetic Biology Research Centres, while £8M will be used for research developing synthetic DNA fragments.

NEW YORK (GenomeWeb) – The UK government will invest £125 million ($200.2 million) in the training and development of 1,250 new students pursuing PhDs in the life sciences, agriculture, and biotechnology, Business Secretary Vince Cable announced today.

NEW YORK (GenomeWeb) – Three US funding agencies, along with partners in the UK and Israel, will provide up to $12 million next year to support multidisciplinary research projects that will use genomics and a wide range of other methods to better understand how infectious disease pathogens are tr

NEW YORK (GenomeWeb) – Three UK science funding agencies have jointly contributed £5.6 million ($9.4 million) toward the European X-ray Free Electron Lasers (XFEL) project, a facility currently under construction in Hamburg, Germany that will provide scientists with access to advanced crystallogr

NEW YORK (GenomeWeb News) – The UK is investing £12 million ($19.9 million) to establish new synthetic biology facilities and provide training in the field, the Biotechnology and Biological Sciences Research Council announced on Wednesday.

NEW YORK (GenomeWeb News) – A pilot opportunity was launched on Tuesday by US and UK funding agencies to simplify the funding application process for researchers in the two countries who wish to collaborate on projects.

NEW YORK (GenomeWeb News) – The UK government is providing £40 million ($65.8 million) to fund three new synthetic biology research centers that will serve as key components of a national strategy to ramp up research and industry capabilities in this field.

Pages

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.